Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection
Healthcare professionals are advised to carefully consider the risk and reduce as far as possible any modifiable risk factors
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.